Robert E. Wanerman is a Partner in the Health Care and Life Sciences Practice in the firm's Washington, DC, office. His practice concentrates on reimbursement, regulatory, and compliance matters affecting health care manufacturers, service providers, and investors in health care organizations. He has extensive experience counseling clients in matters arising under the Medicare and Medicaid programs, the False Claims Act, clinical research rules, grant administration rules, the Anti-Kickback and Stark laws, HIPAA, and EMTALA. Mr. Wanerman: •Represents clients in connection with coverage, coding, and reimbursement for medical technologies under Medicare, Medicaid, and commercial health plans •Represents clients in government audits, investigations, administrative hearings, and in litigation arising under the Medicare and Medicaid programs and under the False Claims Act, including negotiating settlements and corporate integrity agreements •Counsels manufacturers and providers on clinical research contracting and compliance •Develops and implements compliance programs and policies for medical device and pharmaceutical manufacturers, hospitals, academic medical centers, and long-term care facilities In addition, he has worked with many foreign companies to introduce them to regulatory issues in the U.S. market. Rob is the author of several book chapters and articles on regulatory compliance for health care manufacturers and providers, and lectures frequently on these topics. Prior to entering private law practice, Rob was an assistant counsel at the U.S. Department of Health and Human Services. Rob is a graduate of The University of Chicago, New York Law School, and the Columbia University School of Public Health.
8:00 AM–7:00 PM Jun 18, 2017 (America - Los Angeles)
Room 1B, Upper Level